Company: LGNZZ
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000886163-25-000012
Chunk: 107

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 2
Chunk 107
---
Item 2.Properties

The following table summarizes our principal facilities leased as of December 31, 2024, including the location and size of each facility, and their designated use. We believe our facilities are adequate for our current and near-term needs, and we will be able to locate additional facilities, as needed. 

45

LocationApproximate Square FeetOperationLease Expiration DateJupiter, FL1,650Corporate headquartersOctober 2026San Diego, CA6,850OfficeMarch 2029Boston, MA6,840OfficeMay 2029Las Vegas, NV4,100OfficeApril 2028Lawrence, KS3,700Office and laboratoryAugust 2032Durham, NC19,300Office and laboratoryJanuary 2032